Bon Secours Cancer Institute at Reynolds Crossing is a clinical research site located in Richmond, Virginia, United States 23230.
Crixeo Health Trust Score: 85/100 (GOOD). This profile has not yet been claimed by the site owner.
Bon Secours Cancer Institute at Reynolds Crossing has participated in 59 clinical trials with 52 currently active.
Therapeutic areas: Metastatic Lung Non-Squamous Non-Small Cell Carcinoma, Recurrent Lung Non-Squamous Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8.
Sponsors: National Cancer Institute (NCI), Alliance for Clinical Trials in Oncology, ECOG-ACRIN Cancer Research Group.
Trust Score: 85/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Bon Secours Cancer Institute at Reynolds Crossing has a Crixeo Trust Score of 85/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Bon Secours Cancer Institute at Reynolds Crossing has 59 clinical trials on record, with 52 currently active. Their work covers Metastatic Lung Non-Squamous Non-Small Cell Carcinoma, Recurrent Lung Non-Squamous Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8.
Yes — Bon Secours Cancer Institute at Reynolds Crossing holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.